| HCP1904 / Hanmi |
NCT04830449: Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients |
|
|
| Completed | 3 | 122 | RoW | HCP1904-2, RLD2001-2 | Hanmi Pharmaceutical Company Limited | Hypertension | 08/21 | 08/21 | | |
NCT04820907: Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients |
|
|
| Completed | 3 | 123 | RoW | HCP1904-1, RLD2001-1 | Hanmi Pharmaceutical Company Limited | Hypertension | 09/21 | 09/21 | | |
NCT05199129: Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients |
|
|
| Completed | 3 | 166 | RoW | HCP1904-3, RLD2001-1 | Hanmi Pharmaceutical Company Limited | Hypertension | 09/22 | 09/22 | | |
NCT05407220: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. |
|
|
| Not yet recruiting | 1 | 16 | RoW | HCP1904-1, HCP1904-3 | Hanmi Pharmaceutical Company Limited | Healthy | 07/22 | 07/22 | | |
NCT05723549: A Study to Evaluate the PK, Safety and Tolerability of HCP1803. |
|
|
| Completed | 1 | 20 | RoW | HCP1803-3, RLD2002, HCP1904-1 | Hanmi Pharmaceutical Company Limited | Healthy | 03/23 | 03/23 | | |